Prepacked chromatography platform 'a key development' for Repligen
Jun 15 2010 Read 1188 Times
Repligen is the subject of a market report from Companies and Markets which lists the acquisition of BioFlash assets, including the prepacked chromatography platform, as the most recent major step forward made by the firm.
The technology allows 'plug and play' chromatography columns to be produced in a prepacked format, making them easier to implement and use.
Named Opus, the range is available in a variety of different bed heights and column diameters, with commercially accessible resins for chromatography analysis also able to be supplied by Repligen.
"The acquisition and launch of the Opus products reflects Repligen's ongoing commitment to leveraging our core competency in bioprocessing into a broader purification product offering to the biopharmaceutical industry," president and chief executive officer Walter C Herlihy said of the acquisition.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Capillary Electrophoresis-Mass Spectrometry for Micro-Metabolomics - Imaged Capillary Iso-Electric Focussing: Background, Status, and Perspectives - High-Throughp...
View all digital editions
Mar 25 2019 Corvallie, OR, USA
Mar 26 2019 Paris, France
Mar 27 2019 Helsinki, Finland
Mar 31 2019 Orlando, FL, USA
Apr 15 2019 Paris, France